State Medicaid programs must cover medication assisted treatment under a new mandatory benefit that takes effect today.

The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 added the benefit to increase access to evidenced-based treatment for opioid use disorder for Medicaid beneficiaries.

Specifically, states must cover all forms of drugs and biologicals that the Food and Drug Administration has approved or licensed for MAT to treat OUD, the Centers for Medicare & Medicaid Services said today in a reminder notice

 

Related News Articles

Headline
As Congress weighs significant changes and cuts to Medicaid, the AHA today hosted a Capitol Hill briefing for congressional staff featuring hospital and health…
Headline
The House Budget Committee May 16 voted 21-16 against advancing the fiscal year 2025 budget reconciliation bill, with five Republicans joining all Democrats in…
Perspective
Public
Three key House committees — Energy and Commerce, Ways and Means, and Agriculture — after long debates and discussions this week advanced their portions of a…
Headline
The House Energy and Commerce Committee today advanced by a 30-24 vote along party lines its portion of the fiscal year 2025 reconciliation bill following a…
Headline
The Centers for Medicare & Medicaid Services May 12 issued a proposed regulation that would change how states may structure provider taxes for purposes of…
Headline
The Coalition to Strengthen America’s Healthcare May 13 released a new 30-second television and digital advertisement about a family considering whether it can…